Lasa Supergenerics To Acquire Property Of Unit N 31 From Abhinandan Rasayan
2018-04-01 Merger and Acquisitions Drugs & Pharmaceuticals Western India
Lasa Supergenerics Limited, pioneer and amongst the leading player in manufacturing of Veterinary APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has entered into agreement to purchase the Property of unit N 31 from its owner viz., Abhinandan Rasayan Private Limited (ARPL) having its fixed assets i.e. land, building, plant & machinery along with all movable & immovable assets in the property situated in MIDC, Anand Nagar, Ambernath (E), Thane. With this acquisition, Lasa took another step towards achieving its long-term goal. Abhinandan N 31 is a state of the art unit, engaged in manufacturing Human and Veterinary APIs. It lacks backward integration and process novelties. Lasa with its core strength of catalytical chemistry and backward integration is in a strong position to take the business of existing APIs from N 31 to new heights.